Visiogene
Business Services · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.visiogene.comRevenue
<$5 MillionIndustry
About Visiogene
Is Visiogene your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Visiogene is spiking on competitors!
Product Launch: Get notified when Visiogene launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Visiogene had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Visiogene
Check if Visiogene has recently received funding, and reach out quickly before it becomes old news!
Visiogene, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Visiogene has new funding data
Earning: See what the market has to say on Visiogene recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Visiogene
Find 3 more new buyers
Compare Similar Companies to Visiogene
Compare insights from companies similar to Visiogene, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Visiogene
Company Profile Activity
Activity Insights
Visiogene is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Visiogene is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Visiogene.
Visiogene Tech Stack
A closer look at the technologies used by Visiogene
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Visiogene
Visiogene is a vertically integrated biotechnology company focused on developing innovative gene and protein delivery technologies, as well as therapies aimed at treating blindness. The company utilizes patented retinal penetrating Adeno-Associated Viruses (AAV-IKV) for gene delivery to the outer retina and a novel chaperone, Nuc1, to enhance the d... Read More